921 related articles for article (PubMed ID: 19734764)
21. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion.
DeCroos FC; Shuler RK; Stinnett S; Fekrat S
Am J Ophthalmol; 2009 Apr; 147(4):627-633.e1. PubMed ID: 19193361
[TBL] [Abstract][Full Text] [Related]
22. [Pars plana vitrectomy and intravitreal triamcinolone for chronic pseudophakic cystoid macular edema].
Bencić G; Vatavuk Z; Mandić Z
Acta Med Croatica; 2006; 60(2):93-6. PubMed ID: 16848195
[TBL] [Abstract][Full Text] [Related]
23. Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: one-year results.
Nomoto H; Shiraga F; Yamaji H; Fukuda K; Baba T; Takasu I; Ohtsuki H
Retina; 2008 Mar; 28(3):427-32. PubMed ID: 18327134
[TBL] [Abstract][Full Text] [Related]
24. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
Veritti D; Lanzetta P; Perissin L; Bandello F
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
[TBL] [Abstract][Full Text] [Related]
25. Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema.
Bardak Y; Cekiç O; Tiğ SU
Eye (Lond); 2006 Dec; 20(12):1357-9. PubMed ID: 16294204
[TBL] [Abstract][Full Text] [Related]
26. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
[TBL] [Abstract][Full Text] [Related]
27. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
28. Improvement of visual acuity one-year after vitreous surgery in eyes with residual triamcinolone acetonide at the macular hole.
Hikichi T; Furukawa Y; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R
Am J Ophthalmol; 2008 Feb; 145(2):267-272. PubMed ID: 18054886
[TBL] [Abstract][Full Text] [Related]
29. Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy.
Ibarra MS; Hermel M; Prenner JL; Hassan TS
Am J Ophthalmol; 2005 May; 139(5):831-6. PubMed ID: 15860288
[TBL] [Abstract][Full Text] [Related]
30. 25-gauge macular surgery: results and complications.
Patelli F; Radice P; Zumbo G; Frisone G; Fasolino G
Retina; 2007; 27(6):750-4. PubMed ID: 17621185
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up results of ilm peeling during vitrectomy surgery for premacular fibrosis.
Schadlu R; Tehrani S; Shah GK; Prasad AG
Retina; 2008 Jun; 28(6):853-7. PubMed ID: 18536602
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
35. Preventing the deposition of triamcinolone in macular hole by use of whole blood in triamcinolone-assisted membrane peeling.
Lai CC; Chuang LH; Wang NK; Yeung L; Chen YP; Hwang YS; Chen KJ; Wu WC
Retina; 2007 Sep; 27(7):932-7. PubMed ID: 17891019
[TBL] [Abstract][Full Text] [Related]
36. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
[TBL] [Abstract][Full Text] [Related]
37. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
Jonas JB; Spandau UH; Kamppeter BA; Harder B
Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
39. Combined cataract surgery, intraocular lens insertion, and vitrectomy in eyes with idiopathic epiretinal membrane.
Alexandrakis G; Chaudhry NA; Flynn HW; Murray TG
Ophthalmic Surg Lasers; 1999 Apr; 30(4):327-8. PubMed ID: 10219044
[TBL] [Abstract][Full Text] [Related]
40. Short-term outcomes of 23-gauge pars plana vitrectomy.
Gupta OP; Ho AC; Kaiser PK; Regillo CD; Chen S; Dyer DS; Dugel PU; Gupta S; Pollack JS
Am J Ophthalmol; 2008 Aug; 146(2):193-197. PubMed ID: 18547538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
